A164060 Stock Overview
Ilooda Co., Ltd. develops, manufactures, and sells medical devices for dermatology, ophthalmology, cosmetic surgery, and dentistry treatments.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Ilooda Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩6,440.00 |
| 52 Week High | ₩11,530.00 |
| 52 Week Low | ₩5,800.00 |
| Beta | 0.29 |
| 1 Month Change | 1.90% |
| 3 Month Change | -0.92% |
| 1 Year Change | -8.39% |
| 3 Year Change | 23.74% |
| 5 Year Change | n/a |
| Change since IPO | -6.79% |
Recent News & Updates
Shareholder Returns
| A164060 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | 5.1% | 6.5% | 0.5% |
| 1Y | -8.4% | 32.1% | 4.7% |
Return vs Industry: A164060 underperformed the KR Medical Equipment industry which returned 32.1% over the past year.
Return vs Market: A164060 underperformed the KR Market which returned 4.7% over the past year.
Price Volatility
| A164060 volatility | |
|---|---|
| A164060 Average Weekly Movement | 5.2% |
| Medical Equipment Industry Average Movement | 6.3% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in KR Market | 11.8% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A164060 has not had significant price volatility in the past 3 months.
Volatility Over Time: A164060's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 112 | n/a | www.ilooda.com |
Ilooda Co., Ltd. develops, manufactures, and sells medical devices for dermatology, ophthalmology, cosmetic surgery, and dentistry treatments. The company’s products include Secret RF, FRAXIS DUO, Secret DUO, VIKINI, CuRAS, ULTRA BEAUJET, VeLux, hyzer me, VELOCE, PENTO, IRIS, RetiCapture, and FRAXIS lasers. Its products are used in face and body treatment applications, including hair removal, tattoo removal, hair bleaching, pigmented lesion, onychomycosis, melasma, skin rejunavation, face and necklines lifting, smile line treatment, stretch marks, hypertrophic and keloid scars, skin tightening, seborrheic keratosis, wrinkle and pore reduction, vascular lesions, toning and texture, resurfacing, whitening, diffuse redness, retinal diseases, acne scars, spider veins, vaginal tightening, urinary incontinence, lentigo, small mole, wart, blemishes, freckles, and hyperhidrosis.
Ilooda Co., Ltd Fundamentals Summary
| A164060 fundamental statistics | |
|---|---|
| Market cap | ₩131.28b |
| Earnings (TTM) | -₩4.30b |
| Revenue (TTM) | ₩56.20b |
2.3x
P/S Ratio-30.5x
P/E RatioIs A164060 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A164060 income statement (TTM) | |
|---|---|
| Revenue | ₩56.20b |
| Cost of Revenue | ₩26.70b |
| Gross Profit | ₩29.50b |
| Other Expenses | ₩33.80b |
| Earnings | -₩4.30b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -210.95 |
| Gross Margin | 52.49% |
| Net Profit Margin | -7.65% |
| Debt/Equity Ratio | 31.8% |
How did A164060 perform over the long term?
See historical performance and comparison